human lung cancer cell line Search Results


human lung cancer cell line  (ATCC)
96
ATCC human lung cancer cell line
Human Lung Cancer Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung cancer cell line/product/ATCC
Average 96 stars, based on 1 article reviews
human lung cancer cell line - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
non small cell lung cancer nsclc adenocarcinoma  (AMS Biotechnology)
94
AMS Biotechnology non small cell lung cancer nsclc adenocarcinoma
Non Small Cell Lung Cancer Nsclc Adenocarcinoma, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non small cell lung cancer nsclc adenocarcinoma/product/AMS Biotechnology
Average 94 stars, based on 1 article reviews
non small cell lung cancer nsclc adenocarcinoma - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
pc9 cell line  (ATCC)
93
ATCC pc9 cell line
Pc9 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pc9 cell line/product/ATCC
Average 93 stars, based on 1 article reviews
pc9 cell line - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
nci h1975 cells genecopoeia sl003 experimental models  (Genecopoeia)
95
Genecopoeia nci h1975 cells genecopoeia sl003 experimental models
Nci H1975 Cells Genecopoeia Sl003 Experimental Models, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nci h1975 cells genecopoeia sl003 experimental models/product/Genecopoeia
Average 95 stars, based on 1 article reviews
nci h1975 cells genecopoeia sl003 experimental models - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
vascular cell adhesion molecule 1  (Boster Bio)
92
Boster Bio vascular cell adhesion molecule 1
Vascular Cell Adhesion Molecule 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vascular cell adhesion molecule 1/product/Boster Bio
Average 92 stars, based on 1 article reviews
vascular cell adhesion molecule 1 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
pre coated ecm e36107 34 t25  (Celprogen Inc)
90
Celprogen Inc pre coated ecm e36107 34 t25
Pre Coated Ecm E36107 34 T25, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pre coated ecm e36107 34 t25/product/Celprogen Inc
Average 90 stars, based on 1 article reviews
pre coated ecm e36107 34 t25 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
m3610734s media  (Celprogen Inc)
90
Celprogen Inc m3610734s media
M3610734s Media, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m3610734s media/product/Celprogen Inc
Average 90 stars, based on 1 article reviews
m3610734s media - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
lung tumor  (Celprogen Inc)
90
Celprogen Inc lung tumor
Lung Tumor, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lung tumor/product/Celprogen Inc
Average 90 stars, based on 1 article reviews
lung tumor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
small cell lung cancer sclc  (AMS Biotechnology)
94
AMS Biotechnology small cell lung cancer sclc
TROP2 expression in various cancer tissues. A, The expression levels of TROP2 in tissue samples from 19 cancer types were analyzed by IHC. Dots indicate TROP2 H -score for each sample, and solid bars indicate the median H -score of each cancer type. B, TROP2 prevalence rates ( x -axis) were calculated as the percentage of samples with TROP2 H -score ≥100. The ranking order of cancer types was based on the TROP2 prevalence rate. C, Plot of percentage of cells from tumor (blue) and corresponding normal tissues (gray) with TROP2 membrane expression determined by IHC. Each dot represents an individual sample. Solid bars indicate the median percent of TROP2-expressing cells for each tissue type. The numbers of specimens used for each cancer type are indicated in the plots. Representative IHC images of TROP2 high (3+), moderate (2+), and low (1+) expression are shown in Supplementary Fig. S3. Adeno, adenocarcinoma; BC, breast carcinoma; Ca., cancer/carcinoma; CRC, colorectal cancer; H&N, head and neck carcinoma; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; HRPC, hormone-resistant prostate cancer; IHC, <t>immunohistochemistry;</t> <t>NSCLC,</t> non-small cell lung cancer; RCC, renal cell renal carcinoma; SCC, squamous carcinoma; <t>SCLC,</t> small cell lung carcinoma; TNBC, triple-negative breast carcinoma.
Small Cell Lung Cancer Sclc, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small cell lung cancer sclc/product/AMS Biotechnology
Average 94 stars, based on 1 article reviews
small cell lung cancer sclc - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
m36107 34e  (Celprogen Inc)
90
Celprogen Inc m36107 34e
TROP2 expression in various cancer tissues. A, The expression levels of TROP2 in tissue samples from 19 cancer types were analyzed by IHC. Dots indicate TROP2 H -score for each sample, and solid bars indicate the median H -score of each cancer type. B, TROP2 prevalence rates ( x -axis) were calculated as the percentage of samples with TROP2 H -score ≥100. The ranking order of cancer types was based on the TROP2 prevalence rate. C, Plot of percentage of cells from tumor (blue) and corresponding normal tissues (gray) with TROP2 membrane expression determined by IHC. Each dot represents an individual sample. Solid bars indicate the median percent of TROP2-expressing cells for each tissue type. The numbers of specimens used for each cancer type are indicated in the plots. Representative IHC images of TROP2 high (3+), moderate (2+), and low (1+) expression are shown in Supplementary Fig. S3. Adeno, adenocarcinoma; BC, breast carcinoma; Ca., cancer/carcinoma; CRC, colorectal cancer; H&N, head and neck carcinoma; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; HRPC, hormone-resistant prostate cancer; IHC, <t>immunohistochemistry;</t> <t>NSCLC,</t> non-small cell lung cancer; RCC, renal cell renal carcinoma; SCC, squamous carcinoma; <t>SCLC,</t> small cell lung carcinoma; TNBC, triple-negative breast carcinoma.
M36107 34e, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m36107 34e/product/Celprogen Inc
Average 90 stars, based on 1 article reviews
m36107 34e - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
small cell lung cancer tissue  (Celprogen Inc)
90
Celprogen Inc small cell lung cancer tissue
TROP2 expression in various cancer tissues. A, The expression levels of TROP2 in tissue samples from 19 cancer types were analyzed by IHC. Dots indicate TROP2 H -score for each sample, and solid bars indicate the median H -score of each cancer type. B, TROP2 prevalence rates ( x -axis) were calculated as the percentage of samples with TROP2 H -score ≥100. The ranking order of cancer types was based on the TROP2 prevalence rate. C, Plot of percentage of cells from tumor (blue) and corresponding normal tissues (gray) with TROP2 membrane expression determined by IHC. Each dot represents an individual sample. Solid bars indicate the median percent of TROP2-expressing cells for each tissue type. The numbers of specimens used for each cancer type are indicated in the plots. Representative IHC images of TROP2 high (3+), moderate (2+), and low (1+) expression are shown in Supplementary Fig. S3. Adeno, adenocarcinoma; BC, breast carcinoma; Ca., cancer/carcinoma; CRC, colorectal cancer; H&N, head and neck carcinoma; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; HRPC, hormone-resistant prostate cancer; IHC, <t>immunohistochemistry;</t> <t>NSCLC,</t> non-small cell lung cancer; RCC, renal cell renal carcinoma; SCC, squamous carcinoma; <t>SCLC,</t> small cell lung carcinoma; TNBC, triple-negative breast carcinoma.
Small Cell Lung Cancer Tissue, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small cell lung cancer tissue/product/Celprogen Inc
Average 90 stars, based on 1 article reviews
small cell lung cancer tissue - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
lung cancer stem cell culture  (Celprogen Inc)
90
Celprogen Inc lung cancer stem cell culture
TROP2 expression in various cancer tissues. A, The expression levels of TROP2 in tissue samples from 19 cancer types were analyzed by IHC. Dots indicate TROP2 H -score for each sample, and solid bars indicate the median H -score of each cancer type. B, TROP2 prevalence rates ( x -axis) were calculated as the percentage of samples with TROP2 H -score ≥100. The ranking order of cancer types was based on the TROP2 prevalence rate. C, Plot of percentage of cells from tumor (blue) and corresponding normal tissues (gray) with TROP2 membrane expression determined by IHC. Each dot represents an individual sample. Solid bars indicate the median percent of TROP2-expressing cells for each tissue type. The numbers of specimens used for each cancer type are indicated in the plots. Representative IHC images of TROP2 high (3+), moderate (2+), and low (1+) expression are shown in Supplementary Fig. S3. Adeno, adenocarcinoma; BC, breast carcinoma; Ca., cancer/carcinoma; CRC, colorectal cancer; H&N, head and neck carcinoma; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; HRPC, hormone-resistant prostate cancer; IHC, <t>immunohistochemistry;</t> <t>NSCLC,</t> non-small cell lung cancer; RCC, renal cell renal carcinoma; SCC, squamous carcinoma; <t>SCLC,</t> small cell lung carcinoma; TNBC, triple-negative breast carcinoma.
Lung Cancer Stem Cell Culture, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lung cancer stem cell culture/product/Celprogen Inc
Average 90 stars, based on 1 article reviews
lung cancer stem cell culture - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


TROP2 expression in various cancer tissues. A, The expression levels of TROP2 in tissue samples from 19 cancer types were analyzed by IHC. Dots indicate TROP2 H -score for each sample, and solid bars indicate the median H -score of each cancer type. B, TROP2 prevalence rates ( x -axis) were calculated as the percentage of samples with TROP2 H -score ≥100. The ranking order of cancer types was based on the TROP2 prevalence rate. C, Plot of percentage of cells from tumor (blue) and corresponding normal tissues (gray) with TROP2 membrane expression determined by IHC. Each dot represents an individual sample. Solid bars indicate the median percent of TROP2-expressing cells for each tissue type. The numbers of specimens used for each cancer type are indicated in the plots. Representative IHC images of TROP2 high (3+), moderate (2+), and low (1+) expression are shown in Supplementary Fig. S3. Adeno, adenocarcinoma; BC, breast carcinoma; Ca., cancer/carcinoma; CRC, colorectal cancer; H&N, head and neck carcinoma; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; HRPC, hormone-resistant prostate cancer; IHC, immunohistochemistry; NSCLC, non-small cell lung cancer; RCC, renal cell renal carcinoma; SCC, squamous carcinoma; SCLC, small cell lung carcinoma; TNBC, triple-negative breast carcinoma.

Journal: Molecular Cancer Therapeutics

Article Title: OBI-992, a Novel TROP2-Targeted Antibody–Drug Conjugate, Demonstrates Antitumor Activity in Multiple Cancer Models

doi: 10.1158/1535-7163.MCT-24-0588

Figure Lengend Snippet: TROP2 expression in various cancer tissues. A, The expression levels of TROP2 in tissue samples from 19 cancer types were analyzed by IHC. Dots indicate TROP2 H -score for each sample, and solid bars indicate the median H -score of each cancer type. B, TROP2 prevalence rates ( x -axis) were calculated as the percentage of samples with TROP2 H -score ≥100. The ranking order of cancer types was based on the TROP2 prevalence rate. C, Plot of percentage of cells from tumor (blue) and corresponding normal tissues (gray) with TROP2 membrane expression determined by IHC. Each dot represents an individual sample. Solid bars indicate the median percent of TROP2-expressing cells for each tissue type. The numbers of specimens used for each cancer type are indicated in the plots. Representative IHC images of TROP2 high (3+), moderate (2+), and low (1+) expression are shown in Supplementary Fig. S3. Adeno, adenocarcinoma; BC, breast carcinoma; Ca., cancer/carcinoma; CRC, colorectal cancer; H&N, head and neck carcinoma; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; HRPC, hormone-resistant prostate cancer; IHC, immunohistochemistry; NSCLC, non-small cell lung cancer; RCC, renal cell renal carcinoma; SCC, squamous carcinoma; SCLC, small cell lung carcinoma; TNBC, triple-negative breast carcinoma.

Article Snippet: Up to 448 formalin-fixed, paraffin-embedded human late-stage tumor tissue samples, representing 19 cancer types [bladder cancer, cervical adenocarcinoma, cervical squamous cell carcinoma (SCC), colorectal cancer, endometrial cancer, esophageal cancer, gallbladder cancer, gastric cancer, head and neck cancer, hormone receptor-positive (HR + ) breast cancer, human epidermal growth factor receptor 2-positive (HER2 + ) breast cancer, non-small cell lung cancer (NSCLC) adenocarcinoma, NSCLC SCC, ovarian adenocarcinoma, pancreatic cancer, prostate cancer, renal cell carcinoma (RCC), small cell lung cancer (SCLC), and triple-negative breast cancer (TNBC)], were purchased from AMS Biotechnology.

Techniques: Expressing, Membrane, Immunohistochemistry